Pharma News, 2025

Rocket ditches blood disorder gene therapy in ongoing pipeline pivot

AAVantgarde Announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the Treatment of Stargardt Disease

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

USFDA issues Form-483 with 4 observations to Lupin's Pithampur Unit-2 facility

Takeda walks away from cell therapy in priority U-turn

Taysha Says FDA Grants Breakthrough Therapy Designation To In Rett Syndrome

Intravitreal Injection of Retinal Progenitor Cells Shows Promise in Preclinical Study for Diabetic Retinopathy

Mercury Bio Reports Positive Results from Preclinical Study Evaluating Novel Drug Delivery Technology Transporting Protein

Mammoth Biosciences to Present Preclinical Data on MB-111 at the European Society of Gene & Cell Therapy 32nd Annual Congress

From Patent to Patient: FDA Policy Ideas to Protect and Speed Medical Innovation

Genmab to acquire Merus shares for $8bn

Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN